FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

William Gradishar

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Procedures

Adjuvant Chemotherapy

Co-author Network

Publications

TOP 3
Priya Kumthekar; Katie McCarthy; Mary Mulcahy; Jyoti Patel; Alfred Rademaker; Michael J Avram; Mary Cianfrocca; William Gradishar; Sean A Grimm; Irene B Helenowski; Virginia G Kaklamani; Jeffrey J Raizer
Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases.
Paul E Goss; William Gradishar; Manfred Kaufmann; Deborah Lindquist; Miguel Martin; Beverly Moy; Joyce O'Shaughnessy; Martine Piccart-Gebhart; Kathleen I Pritchard; Erica Rappold; Ian E Smith; Lisa S Williams; Gursel Aktan; Frances Boyle; Aman U Buzdar; Yanin Chavarri-Guerra; Bent Ejlertsen; Dianne M Finkelstein; Pierre Fumoleau
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.
Virginia G Kaklamani; Seema A Khan; Mario Lacouture; Caitlin Meservey; Vamsi Parimi; Steven Rosen; Denise Scholtens; Kalliopi Siziopikou; Regina Uthe; Jamie H Von Roenn; Jeffrey Wayne; Kevin Bethke; Mary Cianfrocca; Jennifer Gordon; Nora Hansen; Jacqueline S Jeruss; Borko Jovanovic; William Gradishar
Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of William Gradishar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Priya Kumthekar; Katie McCarthy; Mary Mulcahy; Jyoti Patel; Alfred Rademaker; Michael J Avram; Mary Cianfrocca; William Gradishar; Sean A Grimm; Irene B Helenowski; Virginia G Kaklamani; Jeffrey J Raizer
Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases.
Journal of neuro-oncology 2013;112(2):247-55.
2013: Paul E Goss; William Gradishar; Manfred Kaufmann; Deborah Lindquist; Miguel Martin; Beverly Moy; Joyce O'Shaughnessy; Martine Piccart-Gebhart; Kathleen I Pritchard; Erica Rappold; Ian E Smith; Lisa S Williams; Gursel Aktan; Frances Boyle; Aman U Buzdar; Yanin Chavarri-Guerra; Bent Ejlertsen; Dianne M Finkelstein; Pierre Fumoleau
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.
The lancet oncology 2013;14(1):88-96.
2012: Virginia G Kaklamani; Seema A Khan; Mario Lacouture; Caitlin Meservey; Vamsi Parimi; Steven Rosen; Denise Scholtens; Kalliopi Siziopikou; Regina Uthe; Jamie H Von Roenn; Jeffrey Wayne; Kevin Bethke; Mary Cianfrocca; Jennifer Gordon; Nora Hansen; Jacqueline S Jeruss; Borko Jovanovic; William Gradishar
Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib.
Breast cancer research and treatment 2012;132(3):833-42.
2011: Matti Aapro; Paul Bhar; Sergei Tjulandin; William Gradishar
Weekly nab-paclitaxel is safe and effective in ≥65 years old patients with metastatic breast cancer: a post-hoc analysis.
Breast (Edinburgh, Scotland) 2011;20(5):468-74.
2011: Timothy K Huyck; William Gradishar; Fil Manuguid; Peter Kirkpatrick
Eribulin mesylate.
Nature reviews. Drug discovery 2011;10(3):173-4.
2011: Beatrice J Edwards; Dennis W Raisch; Veena Shankaran; June M McKoy; William Gradishar; Andrew D Bunta; Athena T Samaras; Simone N Boyle; Charles L Bennett; Dennis P West; Theresa A Guise
Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(3):560-8.
2010: Virginia G Kaklamani; Mary Cianfrocca; Jennifer Ciccone; Kelly Kindy; Alfred Rademaker; Elizabeth Louise Wiley; William Gradishar; Ruth M O'Regan
Increased HER2/neu expression in recurrent hormone receptor-positive breast cancer.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2010;15(2):191-3.
2010: George Dranitsaris; Robert Coleman; William Gradishar
nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial.
Breast cancer research and treatment 2010;119(3):717-24.
2009: William Gradishar
Skeletal issues and bone health in patients with cancer. Introduction.
Oncology (Williston Park, N.Y.) 2009;23(14 Suppl 5):7-8.
2009: Mary Cianfrocca; William Gradishar
New molecular classifications of breast cancer.
CA: a cancer journal for clinicians 2009;59(5):303-13.
2009: William Gradishar
Management of advanced breast cancer with the epothilone B analog, ixabepilone.
Drug design, development and therapy 2009;3():163-71.
2008: Stephen Chia; William Gradishar
Fulvestrant: expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancer.
Breast (Edinburgh, Scotland) 2008;17 Suppl 3():S16-21.
2008: Stephen Chia; William Gradishar; Louis Mauriac; Jose Bines; Frederic Amant; Miriam Federico; Luis Fein; Gilles Romieu; Aman Buzdar; John F R Robertson; Adam Brufsky; Kurt Possinger; Pamela Rennie; Francisco Sapunar; Elizabeth Lowe; Martine Piccart
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1664-70.
2008: Julie R Gralow; Hope Rugo; William Gradishar; Joyce A O'Shaughnessy; Mohammad Jahanzeb; Edith Perez; Debu Tripathy
Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtable.
Clinical breast cancer 2008;8(1):33-7.
2007: Affaan K Bangash; Bassel Atassi; Virginia G Kaklamani; Thomas K Rhee; Maurice Yu; Robert J Lewandowski; Kent T Sato; Robert K Ryu; Vanessa L Gates; Steven Newman; Robert Mandal; William Gradishar; Reed A Omary; Riad Salem
90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
Journal of vascular and interventional radiology : JVIR 2007;18(5):621-8.
2006: William Gradishar
Landmark trials in endocrine adjuvant therapy for breast carcinoma.
Cancer 2006;106(5):975-81.
2005: William Gradishar
Fulvestrant in the treatment of postmenopausal women with advanced breast cancer.
Expert review of anticancer therapy 2005;5(3):445-53.
2002: Karen Antman; Ana F Abraido-Lanza; Diane Blum; Erica Brownfield; Barbara Cicatelli; Mary Dale Debor; Karen M Emmons; Marian L Fitzgibbon; Susan M Gapstur; William Gradishar; Robert A Hiatt; F Allan Hubbell; Andrew K Joe; Ann C Klassen; Nancy C Lee; Hannah M Linden; Juliet McMullin; Shiraz I Mishra; Charlotte Neuhaus; Funmi I Olopade; Kathleen Walas
Reducing disparities in breast cancer survival: a Columbia University and Avon Breast Cancer Research and Care Network Symposium.
Breast cancer research and treatment 2002;75(3):269-80.
2002: Monica Morrow; William Gradishar
Breast cancer.
BMJ (Clinical research ed.) 2002;324(7334):410-4.